| Literature DB >> 29789805 |
Jelili Oyelade1,2, Itunuoluwa Isewon1,2, Efosa Uwoghiren1,2, Olufemi Aromolaran1,2, Olufunke Oladipupo1.
Abstract
Malaria is an infectious disease that affects close to half a million individuals every year and Plasmodium falciparum is a major cause of malaria. The treatment of this disease could be done effectively if the essential enzymes of this parasite are specifically targeted. Nevertheless, the development of the parasite in resisting existing drugs now makes discovering new drugs a core responsibility. In this study, a novel computational model that makes the prediction of new and validated antimalarial drug target cheaper, easier, and faster has been developed. We have identified new essential reactions as potential targets for drugs in the metabolic network of the parasite. Among the top seven (7) predicted essential reactions, four (4) have been previously identified in earlier studies with biological evidence and one (1) has been with computational evidence. The results from our study were compared with an extensive list of seventy-seven (77) essential reactions with biological evidence from a previous study. We present a list of thirty-one (31) potential candidates for drug targets in Plasmodium falciparum which includes twenty-four (24) new potential candidates for drug targets.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29789805 PMCID: PMC5896307 DOI: 10.1155/2018/8985718
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Figure 1A network tree which paints the essentiality of each node to the survival of the tree [41].
Results using our method to validate existing potential drug target predicted computationally [18].
| S/N | Reaction | EC number | Yeh et al. [ | Fatumo et al. [ | Huthmacher et al. [ | Plata et al. [ | Bazzani et al. [ | Chiappino-Pepe et al. [ | This |
|---|---|---|---|---|---|---|---|---|---|
| (1) | DIHYDROFOLATEREDUCT-RXN | 1.5.1.3 | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| (2) | THYMIDYLATESYN-RXN | 2.1.1.45 | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| (3) | H2PTEROATESYNTH-RXN | 2.5.1.15 | Yes | Yes | Yes | Yes | No | No | Yes |
| (4) | IMP-DEHYDROG-RXN | 1.1.1.205 | Yes | Yes | Yes | No | Yes | No | Yes |
| (5) | SUPEROX-DISMUT-RXN | 1.15.1.1 | Yes | Yes | Yes | No | Yes | No | Yes |
| (6) | ADENOSYLHOMOCYSTEINASE-RXN | 3.3.11 | Yes | Yes | Yes | No | Yes | No | Yes |
| (7) | OROTPDECARB-RXN | 4.1.1.23 | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| (8) | SAMDECARB-RXN | 4.1.1.50 | Yes | Yes | Yes | Yes | Yes | No | Yes |
| (9) | PORPHOBILSYNTH-RXN | 4.2.1.24 | Yes | Yes | Yes | Yes | Yes | No | Yes |
| (10) | GLUTCYSLIG-RXN | 6.3.2.2 | Yes | Yes | Yes | No | Yes | No | Yes |
The top seven predicted most essential reactions from this study.
| S/N | Reaction | Gene ID | Common name | EC number | Number of affected reactions | Essentiality |
|---|---|---|---|---|---|---|
| (1) |
| PFF1130C, PF08_0071 | Superoxide dismutase | 1.15.1.1 | 94 | 1.27027027 |
| (2) | CATAL-RXN | Catalase | 1.11.1.6 | 74 | 1 | |
| (3) |
| PFI1090W | Methionine adenosyltransferase | 2.5.1.6 | 49 | 0.662162162 |
| (4) |
| 3-Phosphoshikimate 1-carboxyvinyltransferase | 2.5.1.19 | 48 | 0.648648649 | |
| (5) |
| PFF1105C | 5-O-(1-Carboxyvinyl)-3-phosphoshikimate phosphate-lyase | 4.2.3.5 | 48 | 0.648648649 |
| (6) | SHIKIMATE-KINASE-RXN | Shikimate kinase | 2.7.1.71 | 48 | 0.648648649 | |
| (7) |
| PFE1050W | Adenosylhomocysteinase | 3.3.1.1 | 39 | 0.527027027 |
31 potential reactions for drug targets in Plasmodium falciparum from this study.
| S/N | Reaction | Gene ID | Common name | EC number |
|---|---|---|---|---|
| (1) | CATAL-RXN | ORPHAN | Catalase | 1.11.1.6 |
| (2) | RXN-1321 | ORPHAN | Linoleate 13S-lipoxygenase | 1.13.11.12 |
| (3) | 12-OXOPHYTODIENOATE-REDUCTASE-RXN | ORPHAN | 12-Oxophytodienoate reductase | 1.3.1.42 |
| (4) |
| PF11_0436 | Coproporphyrinogen oxidase | 1.3.3.3 |
| (5) | AICARTRANSFORM-RXN | ORPHAN | Phosphoribosylaminoimidazolecarboxamide formyltransferase | 2.1.2.3 |
| (6) |
| PF14_0484 | Acetyl-CoA C-acetyltransferase | 2.3.1.9 |
| (7) |
| PFI1090W | Methionine adenosyltransferase | 2.5.1.6 |
| (8) |
| PFL0480W | Hydroxymethylbilane synthase | 2.5.1.61 |
| (9) |
| PFF0435W | Acetylornithine transaminase | 2.6.1.11 |
| (10) |
| PFF0435W |
| 2.6.1.18 |
| (11) |
| PFI1100W | Aminodeoxychorismate synthase | 2.6.1.85 |
| (12) | SHIKIMATE-KINASE-RXN | ORPHAN | Shikimate kinase | 2.7.1.71 |
| (13) | UDPKIN-RXN | ORPHAN | Nucleoside-diphosphate kinase | 2.7.4.6 |
| (14) |
| PFL2465C | dTMP kinase | 2.7.4.9 |
| (15) |
| PF08_0095 | 2-Amino-4-hydroxy-6-hydroxymethyldihydropteridine diphosphokinase | 2.7.6.3 |
| (16) |
| PF13_0159 | Nicotinate-nucleotide adenylyltransferase | 2.7.7.18 |
| (17) |
| MAL13P1.218 | UDP-N-acetylglucosamine diphosphorylase | 2.7.7.23 |
| (18) |
| MAL13P1.218 | UTP—glucose-1-phosphate uridylyltransferase | 2.7.7.9 |
| (19) |
| PFC0935C | UDP-N-acetylglucosamine—dolichyl-phosphate N-acetylglucosaminephosphotransferase | 2.7.8.15 |
| (20) |
| PFL1940W | 3-Hydroxyisobutyryl-CoA hydrolase | 3.1.2.4 |
| (21) |
| PFL1940W | 3-Hydroxyisobutyryl-CoA hydrolase | 3.1.2.4 |
| (22) | IMPCYCLOHYDROLASE-RXN | ORPHAN | IMP cyclohydrolase | 3.5.4.10 |
| (23) |
| PFL1155W | GTP cyclohydrolase I | 3.5.4.16 |
| (24) |
| PFF0360W | Uroporphyrinogen decarboxylase | 4.1.1.37 |
| (25) |
| PFI1100W | Aminodeoxychorismate lyase | 4.1.3.38 |
| (26) |
| PF14_0381 | Porphobilinogen synthase | 4.2.1.24 |
| (27) |
| ORPHAN | Uroporphyrinogen-III synthase | 4.2.1.75 |
| (28) | RXN1F-19 | ORPHAN | Hydroperoxide dehydratase | 4.2.1.92 |
| (29) | ALLENE-OXIDE-CYCLASE-RXN | ORPHAN | Allene-oxide cyclase | 5.3.99.6 |
| (30) |
| PF13_0205, PFL2485C | Tryptophan—tRNA ligase | 6.1.1.2 |
| (31) |
| PF14_0428 | Histidine—tRNA ligase | 6.1.1.21 |